| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Jun 2024 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 799.98M | 858.78M | 868.21M | 944.79M | 820.54M |
| Gross Profit | 225.24M | 240.95M | 242.07M | 279.94M | 258.14M |
| EBITDA | 169.02M | 86.18M | -34.77M | -623.05M | 157.23M |
| Net Income | 125.71M | 8.16M | -80.91M | -664.34M | 100.48M |
Balance Sheet | |||||
| Total Assets | 710.90M | 685.03M | 626.81M | 601.92M | 1.23B |
| Cash, Cash Equivalents and Short-Term Investments | 35.64M | 135.18M | 48.04M | 22.72M | 631.78M |
| Total Debt | 14.57M | 24.54M | 29.90M | 41.27M | 54.40M |
| Total Liabilities | 689.65M | 793.10M | 738.62M | 636.03M | 599.75M |
| Stockholders Equity | -1.40M | -130.46M | -138.62M | -57.76M | 606.58M |
Cash Flow | |||||
| Free Cash Flow | 32.24M | 32.98M | 38.61M | 44.06M | 90.56M |
| Operating Cash Flow | 35.60M | 36.63M | 48.91M | 52.33M | 103.00M |
| Investing Cash Flow | -47.00M | -5.65M | -10.25M | -365.03M | -407.56M |
| Financing Cash Flow | -15.43M | -18.26M | -13.35M | -16.37M | 41.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$623.82M | 3.13 | 8.89% | 6.25% | 3.66% | 10.37% | |
70 Outperform | HK$237.21M | 2.68 | 15.16% | 11.22% | 4.17% | 10.89% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
50 Neutral | HK$228.55M | -6.60 | 3151.98% | ― | -4.36% | 1481.82% | |
50 Neutral | HK$172.60M | 13.46 | 1.53% | ― | -7.13% | -14.57% | |
49 Neutral | HK$370.02M | 11.39 | 0.54% | ― | 7.29% | 10.87% |